​

Ocugen (OCGN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ocugen Revenue Highlights

Latest Revenue (Y)

$4.05M

Latest Revenue (Q)

$1.75M

Ocugen Revenue by Period

Ocugen Revenue by Year

DateRevenueChange
2024-12-31$4.05M-32.82%
2023-12-31$6.04M142.60%
2022-12-31$2.49M100.00%
2021-12-31--100.00%
2020-12-31$42.62K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--100.00%
2013-12-31$8.00K-69.23%
2012-12-31$26.00K-

Ocugen generated $4.05M in revenue during NA 2024, up -32.82% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Ocugen Revenue by Quarter

DateRevenueChange
2025-09-30$1.75M27.60%
2025-06-30$1.37M-7.29%
2025-03-31$1.48M93.85%
2024-12-31$764.00K-32.75%
2024-09-30$1.14M-0.44%
2024-06-30$1.14M12.52%
2024-03-31$1.01M-83.20%
2023-12-31$6.04M63.18%
2023-09-30$3.70M100.00%
2023-06-30--100.00%
2023-03-31$443.00K100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$42.58M100.00%
2020-09-30--100.00%
2020-06-30$42.62K100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31--100.00%
2013-09-30$3.00K-

Ocugen generated $1.75M in revenue during Q3 2025, up 27.60% compared to the previous quarter, and up 153.55% compared to the same period a year ago.

Ocugen Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADCTADC Therapeutics$69.28M$15.75M
LXRXLexicon Pharmaceuticals$31.08M$14.18M
OCGNOcugen$4.05M$1.75M
FULCFulcrum Therapeutics$2.81M-
ALMSAlumis-$2.67M
RAPTRAPT Therapeutics--
CMPXCompass Therapeutics--
NGNENeurogene--
NMRANeumora Therapeutics--
OMEROmeros--

OCGN Revenue FAQ

What is Ocugen’s yearly revenue?

Ocugen's yearly revenue for 2024 was $4.06M, representing a decrease of -32.82% compared to 2023. The company's yearly revenue for 2023 was $6.04M, representing an increase of 142.60% compared to 2022. OCGN's yearly revenue for 2022 was $2.49M, representing an increase of 100.00% compared to 2021.

What is Ocugen’s quarterly revenue?

Ocugen's quarterly revenue for Q3 2025 was $1.75M, a 27.60% increase from the previous quarter (Q2 2025), and a 54.23% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.37M, a -7.29% decrease from the previous quarter (Q1 2025), and a 20.33% increase year-over-year (Q2 2024). OCGN's quarterly revenue for Q1 2025 was $1.48M, a 93.85% increase from the previous quarter (Q4 2024), and a 46.06% increase year-over-year (Q1 2024).

What is Ocugen’s revenue growth rate?

Ocugen's revenue growth rate for the last 3 years (2022-2024) was 62.98%, and for the last 5 years (2020-2024) was 9414.31%.